$ICUI
ICU Medical Inc

2013 Q2 Form 10-Q Financial Statement

#000088398413000036 Filed on July 25, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $78.66M $77.28M
YoY Change 1.79% -0.66%
Cost Of Revenue $40.62M $38.20M
YoY Change 6.35% -8.16%
Gross Profit $38.04M $39.08M
YoY Change -2.67% 7.96%
Gross Profit Margin 48.36% 50.57%
Selling, General & Admin $23.18M $22.81M
YoY Change 1.65% 15.59%
% of Gross Profit 60.94% 58.35%
Research & Development $3.906M $2.729M
YoY Change 43.13% 9.55%
% of Gross Profit 10.27% 6.98%
Depreciation & Amortization $4.900M $4.700M
YoY Change 4.26% 2.17%
% of Gross Profit 12.88% 12.03%
Operating Expenses $27.09M $25.54M
YoY Change 6.08% 14.91%
Operating Profit $10.95M $13.55M
YoY Change -19.17% -3.1%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $212.0K $145.0K
YoY Change 46.21% -66.36%
Pretax Income $11.16M $13.69M
YoY Change -18.48% -4.99%
Income Tax $3.795M $4.543M
% Of Pretax Income 34.0% 33.18%
Net Earnings $7.367M $9.149M
YoY Change -19.48% -3.62%
Net Earnings / Revenue 9.37% 11.84%
Basic Earnings Per Share $0.50 $0.65
Diluted Earnings Per Share $0.48 $0.63
COMMON SHARES
Basic Shares Outstanding 14.62M shares 14.18M shares
Diluted Shares Outstanding 15.22M shares 14.62M shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $244.0M $193.5M
YoY Change 26.1% 60.18%
Cash & Equivalents $170.6M $121.6M
Short-Term Investments $73.40M $71.90M
Other Short-Term Assets $11.00M $10.30M
YoY Change 6.8% -16.94%
Inventory $36.28M $36.54M
Prepaid Expenses
Receivables $49.55M $43.84M
Other Receivables $5.400M $9.300M
Total Short-Term Assets $346.2M $293.4M
YoY Change 17.98% 22.84%
LONG-TERM ASSETS
Property, Plant & Equipment $88.99M $82.18M
YoY Change 8.29% -6.15%
Goodwill $1.478M $1.478M
YoY Change 0.0% 0.0%
Intangibles $9.272M $10.75M
YoY Change -13.74% -22.0%
Long-Term Investments
YoY Change
Other Assets $5.600M $4.800M
YoY Change 16.67% 4.35%
Total Long-Term Assets $105.4M $99.15M
YoY Change 6.28% -7.73%
TOTAL ASSETS
Total Short-Term Assets $346.2M $293.4M
Total Long-Term Assets $105.4M $99.15M
Total Assets $451.6M $392.6M
YoY Change 15.02% 13.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.73M $12.28M
YoY Change -4.44% -0.25%
Accrued Expenses $16.30M $17.55M
YoY Change -7.12% 21.26%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $28.03M $29.83M
YoY Change -6.02% 11.37%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.300M $4.100M
YoY Change -19.51% -8.89%
Total Long-Term Liabilities $3.300M $4.100M
YoY Change -19.51% -8.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $28.03M $29.83M
Total Long-Term Liabilities $3.300M $4.100M
Total Liabilities $37.00M $41.10M
YoY Change -9.98% 4.85%
SHAREHOLDERS EQUITY
Retained Earnings $358.2M $317.6M
YoY Change 12.78% 14.93%
Common Stock $69.53M $61.69M
YoY Change 12.72% 6.61%
Preferred Stock
YoY Change
Treasury Stock (at cost) $10.54M $22.54M
YoY Change -53.25% -27.59%
Treasury Stock Shares 207.0K shares
Shareholders Equity $414.6M $351.5M
YoY Change
Total Liabilities & Shareholders Equity $451.6M $392.6M
YoY Change 15.02% 13.36%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income $7.367M $9.149M
YoY Change -19.48% -3.62%
Depreciation, Depletion And Amortization $4.900M $4.700M
YoY Change 4.26% 2.17%
Cash From Operating Activities $15.20M $13.20M
YoY Change 15.15% 28.16%
INVESTING ACTIVITIES
Capital Expenditures -$6.200M -$4.900M
YoY Change 26.53% 0.0%
Acquisitions
YoY Change
Other Investing Activities $5.100M -$11.90M
YoY Change -142.86% -358.7%
Cash From Investing Activities -$1.100M -$16.80M
YoY Change -93.45% 16700.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.300M 4.800M
YoY Change -72.92% -20.0%
NET CHANGE
Cash From Operating Activities 15.20M 13.20M
Cash From Investing Activities -1.100M -16.80M
Cash From Financing Activities 1.300M 4.800M
Net Change In Cash 15.40M 1.200M
YoY Change 1183.33% -92.59%
FREE CASH FLOW
Cash From Operating Activities $15.20M $13.20M
Capital Expenditures -$6.200M -$4.900M
Free Cash Flow $21.40M $18.10M
YoY Change 18.23% 19.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
11732000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11308000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
49127000 USD
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
49551000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17810000 USD
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16298000 USD
CY2013Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
119317000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
112836000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1429000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2650000 USD
CY2013Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
68048000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
63770000 USD
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
998000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3000 shares
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5000 shares
CY2012Q4 us-gaap Assets
Assets
428512000 USD
CY2013Q2 us-gaap Assets
Assets
451562000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
325503000 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
346185000 USD
CY2013Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
73395000 USD
CY2012Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
79259000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
77000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
228000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
170588000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
146900000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99590000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
121560000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
23688000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
21970000 USD
CY2012Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
226159000 USD
CY2013Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
243983000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14855000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14855000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14458000 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14468000 shares
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
1486000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
1486000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
14733000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
8516000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
14831000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5045000 USD
CY2013Q2 us-gaap Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value
ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
0 USD
CY2012Q4 us-gaap Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value
ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
0 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
78745000 USD
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
38199000 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-387000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
78128000 USD
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
40623000 USD
CY2013Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
4555000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
4293000 USD
CY2013Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
5638000 USD
CY2012Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
5642000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5247000 USD
CY2013Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
5685000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9589000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9533000 USD
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="font-family:Times New Roman;font-size:10pt;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Note 2:</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">New Accounting Pronouncements:</font></div></td></tr></table><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2013, the Financial Accounting Standards Board issued Accounting Standards Update ("ASU") number 2013-02, Other Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income to improve the reporting of reclassifications out of accumulated other comprehensive income. ASU 2013-02 requires reporting the effect of significant reclassifications out of accumulated other comprehensive income on the respective line items in net income. It is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2012. The adoption of this ASU does not affect our consolidated financial statements, but could require additional disclosure if applicable in future periods.</font></div></div>
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.50
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.65
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.10
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.06
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.63
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-938000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-636000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.34
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.31
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
3084000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
2758000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-27000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
20000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
1478000 USD
CY2013Q2 us-gaap Goodwill
Goodwill
1478000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
38038000 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
39082000 USD
us-gaap Gross Profit
GrossProfit
74832000 USD
us-gaap Gross Profit
GrossProfit
74047000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
11162000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
13692000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
25209000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
23355000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3795000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8459000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7303000 USD
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4543000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
208000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-608000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
623000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
850000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1582000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1035000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
186000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3707000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-649000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-821000 USD
CY2012Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
441000 shares
CY2013Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
599000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
417000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
585000 shares
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9952000 USD
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
9272000 USD
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
12512000 USD
CY2013Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13709000 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
36281000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
36333000 USD
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
20808000 USD
CY2013Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
18160000 USD
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
3013000 USD
CY2013Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
4412000 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
1338000 USD
us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
985000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
451562000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
428512000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
29118000 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
28030000 USD
CY2012Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
3290000 USD
CY2013Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
3290000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13172000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6480000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8112000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21736000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
31472000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25956000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
380000 USD
CY2012Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
145000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
280000 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
212000 USD
us-gaap Operating Expenses
OperatingExpenses
49118000 USD
us-gaap Operating Expenses
OperatingExpenses
51857000 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
27088000 USD
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
25535000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
10950000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
22975000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
24929000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
13547000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1221000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2017000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4104000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1149000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
230000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-682000 USD
us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-263000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8222000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
53966000 USD
CY2013Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
124000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
270000 USD
CY2012Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
142000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
250000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
620000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
633000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
45368000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11781000 USD
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7271000 USD
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6384000 USD
CY2012Q4 us-gaap Prepaid Taxes
PrepaidTaxes
2320000 USD
CY2013Q2 us-gaap Prepaid Taxes
PrepaidTaxes
5431000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
41062000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
49650000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
10000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
20000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3921000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9333000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1081000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1267000 USD
us-gaap Profit Loss
ProfitLoss
16750000 USD
us-gaap Profit Loss
ProfitLoss
16052000 USD
CY2012Q2 us-gaap Profit Loss
ProfitLoss
9149000 USD
CY2013Q2 us-gaap Profit Loss
ProfitLoss
7367000 USD
CY2013Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
208306000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
198773000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
85937000 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
88989000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-152000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
40000 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2729000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5809000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3906000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5422000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
342158000 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
358210000 USD
CY2012Q2 us-gaap Revenues
Revenues
77281000 USD
us-gaap Revenues
Revenues
152792000 USD
CY2013Q2 us-gaap Revenues
Revenues
78661000 USD
us-gaap Revenues
Revenues
152960000 USD
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
77139000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
152522000 USD
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
78537000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
152710000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
43696000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
46048000 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23182000 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22806000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2822000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3042000 USD
CY2013Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
414557000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
390857000 USD
CY2013Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
207000 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
397000 shares
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
15128000 USD
CY2013Q2 us-gaap Treasury Stock Value
TreasuryStockValue
10537000 USD
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14620000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15147000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14484000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15216000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14562000 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14179000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14617000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14067000 shares
CY2012Q3 icui Debt Securities Maturity Date Range High
DebtSecuritiesMaturityDateRangeHigh
2042
CY2012Q3 icui Debt Securities Maturity Date Range Low
DebtSecuritiesMaturityDateRangeLow
2013
icui Increase Decrease In Prepaid And Deferred Income Taxes
IncreaseDecreaseInPrepaidAndDeferredIncomeTaxes
-2894000 USD
icui Increase Decrease In Prepaid And Deferred Income Taxes
IncreaseDecreaseInPrepaidAndDeferredIncomeTaxes
-3612000 USD
icui Provision For Warranty And Returns
ProvisionForWarrantyAndReturns
16000 USD
icui Provision For Warranty And Returns
ProvisionForWarrantyAndReturns
247000 USD
icui Treasurystockacquiredinshareawardsswapforincometaxes
Treasurystockacquiredinshareawardsswapforincometaxes
27260 shares
icui Treasurystockacquiredshareawardsswapfortaxpayments
Treasurystockacquiredshareawardsswapfortaxpayments
1792000 USD
icui Treasurystockacquiredshareawardsswapfortaxpayments
Treasurystockacquiredshareawardsswapfortaxpayments
0 USD
icui Treasuystockacquiredfromshareawardsswap
Treasuystockacquiredfromshareawardsswap
55704 shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000883984
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14650573 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
ICU MEDICAL INC/DE

Files In Submission

Name View Source Status
0000883984-13-000036-index-headers.html Edgar Link pending
0000883984-13-000036-index.html Edgar Link pending
0000883984-13-000036.txt Edgar Link pending
0000883984-13-000036-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
icui-20130630.xml Edgar Link completed
icui-20130630.xsd Edgar Link pending
icui-20130630_cal.xml Edgar Link unprocessable
icui-20130630_def.xml Edgar Link unprocessable
icui-20130630_lab.xml Edgar Link unprocessable
icui-20130630_pre.xml Edgar Link unprocessable
icui-ex311_20130630x10q.htm Edgar Link pending
icui-ex312_x20130630x10q.htm Edgar Link pending
icui-ex321_x20130630x10q.htm Edgar Link pending
icui0630201310-q.htm Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending